New pill takes on tough breast cancer in first human trial
Disease control
Not yet recruiting
This study tests a new oral drug called Zn-Telomir in people with advanced or metastatic triple-negative breast cancer (TNBC) who have already tried other treatments. The trial has two parts: first, finding a safe dose, and second, checking if the drug shrinks tumors. About 76 ad…
Phase: PHASE1, PHASE2 • Sponsor: Telomir Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 03:55 UTC